Distinguished physician, informaticist and AI product leader to guide Drive Health’s clinical strategy, AI governance and workflow validation
Drive Health, a Phoenix‑based digital health startup advancing patient-centered care, announced the appointment of Dr. Matthew G. Crowson, MD, MPA, MASc, MBI, as Chief Medical Officer (CMO). Dr. Crowson is a dual board‑certified physician and informaticist whose unique blend of clinical credibility and technical expertise positions him as one of the leading voices in medical artificial intelligence. As CMO, he will guide Drive Health’s clinical strategy by leading AI governance and workflow validation as the company accelerates the safe, evidence‑based use of AI in frontline healthcare.
Health Technology Insights: Revvity Launches Somatic Cancer Standards with MDIC and NIST
Dr. Crowson brings a track record of translating cutting‑edge AI innovation into real‑world clinical impact. Educated at Dartmouth College (M.D.), Harvard Medical School (Master of Biomedical Informatics), the University of Toronto (Master of Applied Science) and the Royal Military College of Canada (Master of Public Administration), his academic pedigree spans medicine, engineering and public policy. He has authored more than 100 peer‑reviewed publications and book chapters, and is an internationally recognized keynote speaker and patented inventor in medical AI. Across academia, consulting and industry, he has earned a reputation as a rare “triple‑threat” operator: able to design the algorithm, build the business case and lead the clinical execution that makes AI work.
Health Technology Insights: City Therapeutics Files CITY-FXI RNAi Trial for Blood Clots
“Dr. Crowson’s appointment marks a pivotal milestone for Drive Health,” said Kevin Longoria, co‑founder and CEO of Drive Health. “We believe that safe, agentic AI will only gain traction in healthcare when clinicians trust it, and there is no one better suited to earn that trust than Dr. Crowson. His rare combination of surgical training, deep machine‑learning expertise and product leadership will help us translate artificial intelligence into solutions that truly improve the lives of nurses, physicians and patients.”
Before joining Drive Health, Dr. Crowson served as Director of AI/Generative AI Product Management at Wolters Kluwer Health, where he oversaw the development of enterprise‑grade AI products for healthcare clients. He previously served as a Healthcare AI Leader at Deloitte, helping major health systems design and operationalize AI platforms. In addition to his industry roles, Dr. Crowson is a part-time Assistant Professor at Harvard Medical School and a fellowship-trained otolaryngology-head and neck surgeon at Mass Eye and Ear. He also advises early‑stage health‑tech firms and serves on multiple advisory boards, providing guidance on AI governance, product validation and evidence‑generation frameworks.
“I have spent my career building AI systems that solve real problems for clinicians and patients,” said Dr. Crowson. “Drive Health understands that technology must fit into existing workflows and be held to the same standards of evidence and safety as any medical innovation. I’m humbled to join an organization that shares my commitment to pragmatic, human‑centered AI, and I look forward to working alongside Drive Health’s exceptional team to advance the responsible adoption of agentic AI across healthcare.”
Dr. Crowson will work hand in hand with Drive Health Chief Nursing Officer Dr. Leeza Constantoulakis, PhD, RN, to ensure that practicing clinicians directly shape how AI closes gaps in care delivery and drives health equity. His appointment underscores Drive Health’s broader commitment to partnering with clinicians and industry leaders as it scales Avery, its agentic AI co‑pilot platform.
“Dr. Crowson is a thought-leader with the practical experience needed to really make an impact,” said Dr. Constantoulakis. “His deep understanding of both patient care and product design has already elevated our work. I’m thrilled to welcome him to our leadership team and to collaborate on new programs that will ensure our approach to re-imagining clinical workflows is held to the highest clinical and professional standards.”
Health Technology Insights: Talkspace Launches Chapters to Support Women’s Mental Health
To participate in our interviews, please write to our HealthTech Media Room at info@intentamplify.com
Source- businesswire
